These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3756626)

  • 21. Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats.
    Fekete M; Lengyel A; Hegedüs B; Penke B; Zarándy M; Tóth G; Telegdy G
    Eur J Pharmacol; 1984 Feb; 98(1):79-91. PubMed ID: 6325212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
    Crawley JN; Stivers JA; Hommer DW; Skirboll LR; Paul SM
    J Pharmacol Exp Ther; 1986 Feb; 236(2):320-30. PubMed ID: 3003339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behaviour of rats.
    Fekete M; Szabó A; Balázs M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(1):39-45. PubMed ID: 6282048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of cholecystokinin octapeptide on ethanol-induced changes in motor activity and in dopamine metabolism in the nucleus accumbens of the rat brain].
    Medvedeva OF; Sudakova SK; Anokhina IP; Kianmaa K
    Eksp Klin Farmakol; 1996; 59(6):44-7. PubMed ID: 9181874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracerebroventricular administration of cholecystokinin-8 elevates plasma pancreatic polypeptide levels in awake dogs.
    Lu QH; Greeley GH; Zhu XG; Thompson JC
    Endocrinology; 1984 Jun; 114(6):2415-7. PubMed ID: 6327247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opposite actions of CCK-8 on amphetamine-induced hyperlocomotion and stereotypy following intracerebroventricular and intra-accumbens injections in rats.
    Weiss F; Tanzer DJ; Ettenberg A
    Pharmacol Biochem Behav; 1988 Jun; 30(2):309-17. PubMed ID: 3174761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abdominal vagotomy decreases the satiating potency of CCK-8 in sham and real feeding.
    Joyner K; Smith GP; Gibbs J
    Am J Physiol; 1993 May; 264(5 Pt 2):R912-6. PubMed ID: 8498600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCK-8 elicits grooming: cross tolerance to ACTH1-24.
    Kulkosky PJ; Molello CL; Isaacson RL
    Exp Neurol; 1987 Sep; 97(3):697-703. PubMed ID: 3040461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exogenous cholecystokinin-8 reduces vagal efferent nerve activity in rats through CCK(A) receptors.
    Bucinskaite V; Kurosawa M; Lundeberg T
    Br J Pharmacol; 2000 Apr; 129(8):1649-54. PubMed ID: 10780970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of caerulein and cholecystokinin-octapeptide on acetylcholine and choline contents in the brains of intact and vagotomized mice.
    Miyate H
    Pharmacol Biochem Behav; 1990 Jan; 35(1):143-9. PubMed ID: 2315352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: role of corticotropin-releasing hormone.
    Kamilaris TC; Johnson EO; Calogero AE; Kalogeras KT; Bernardini R; Chrousos GP; Gold PW
    Endocrinology; 1992 Apr; 130(4):1764-74. PubMed ID: 1312423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptide.
    Tanimoto K; Tamminga CA; Chase TN; Nilaver G
    Endocrinology; 1987 Jul; 121(1):127-32. PubMed ID: 3297634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of sulfated cholecystokinin octapeptide and cholecystokinin tetrapeptide in rat behavior after blockade of nitric oxide synthase by L-NAME.
    Hoły Z; Wiśniewski K
    Rocz Akad Med Bialymst; 1998; 43():250-70. PubMed ID: 9972062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depression of rat feeding in familiar and novel environment by sulfated and nonsulfated cholecystokinin octapeptide.
    Kádár T; Penke B; Kovács K; Telegdy G
    Physiol Behav; 1985 Mar; 34(3):395-400. PubMed ID: 4011720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exogenous cholecystokinin octapeptide in broiler chickens: satiety, conditioned colour aversion, and vagal mediation.
    Covasa M; Forbes JM
    Physiol Behav; 1994 Jul; 56(1):39-49. PubMed ID: 8084906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholecystokinin changes the duration but not the rate of licking in vagotomized rats.
    Davis JD; Smith GP; Kung TM
    Behav Neurosci; 1995 Oct; 109(5):991-6. PubMed ID: 8554722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is cholecystokinin octapeptide (CCK-8) a candidate for endogenous anti-opioid substrates?
    Han JS; Ding XZ; Fan SG
    Neuropeptides; 1985 Feb; 5(4-6):399-402. PubMed ID: 4000412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of cholecystokinin on self-stimulation behavior in rats.
    Fekete M; Rentzsch A; Schwarzberg H; Telegdy G
    Eur J Pharmacol; 1983 Jul; 91(1):77-82. PubMed ID: 6311574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice.
    Hirosue Y; Inui A; Teranishi A; Miura M; Nakajima M; Okita M; Nakajima Y; Himori N; Baba S; Kasuga M
    Am J Physiol; 1993 Sep; 265(3 Pt 2):R481-6. PubMed ID: 8214137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents.
    Van Ree JM; Gaffori O; De Wied D
    Eur J Pharmacol; 1983 Sep; 93(1-2):63-78. PubMed ID: 6138272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.